Amit Hazan
Stock Analyst at Goldman Sachs
(2.14)
# 2,703
Out of 4,853 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $135.87 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $6.49 | -61.48% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.60 | +1,087.50% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $12.19 | -34.37% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $44.87 | +40.41% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $171.03 | +59.04% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $11.61 | +46.43% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $20.06 | +2,068.49% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $65.05 | -32.36% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $77.77 | -6.13% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $30.15 | +75.79% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $31.60 | +80.38% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $12.44 | -23.63% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $133.94 | -22.35% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $9.11 | +558.62% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $87.00 | +32.18% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $383.10 | -60.85% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $102.83 | -55.27% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $558.06 | -56.69% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $91.92 | +92.56% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $153.66 | -4.33% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.52 | +156.58% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $135.87
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $6.49
Upside: -61.48%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.60
Upside: +1,087.50%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $12.19
Upside: -34.37%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $44.87
Upside: +40.41%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $171.03
Upside: +59.04%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $11.61
Upside: +46.43%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $20.06
Upside: +2,068.49%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $65.05
Upside: -32.36%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $77.77
Upside: -6.13%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $30.15
Upside: +75.79%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $31.60
Upside: +80.38%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $12.44
Upside: -23.63%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $133.94
Upside: -22.35%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $9.11
Upside: +558.62%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $87.00
Upside: +32.18%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $383.10
Upside: -60.85%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $102.83
Upside: -55.27%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $558.06
Upside: -56.69%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $91.92
Upside: +92.56%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $153.66
Upside: -4.33%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.52
Upside: +156.58%